Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
life sciences
national blog main
avapritinib
biotech
blueprint medicines
boston top stories
national top stories
roche
cancer
clinical trials
deals
eli lilly
europe blog main
europe top stories
genentech
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
san francisco blog main
san francisco top stories
selpercatinib
thyroid cancer
andrew berens
biopharma
cancer drugs
capmatinib
cstone pharmaceuticals
deciphera pharmaceuticals
duchenne
european medicines agency
fda
fisogatinib
flatiron health
gastrointestinal stromal tumor
gastrointestinal stromal tumors
gist
gleevec
hepatocellular carcinoma
What
approval
4
×
fda
blueprint
cancer
drug
medicine
medicines
ret
roche
therapy
address
announced
approves
betting
billion
biopharma
candidate
carries
certain
chasing
currently
deadly
deal
deciphera
designed
duchenne
filing
forms
gene
genetic
gi
historic
latest
marketing
morning
muscle
pact
pass
pharamceuticals
plans
Language
unset
4
×
Current search:
boston
×
approval
×
unset
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug